Bicyclic heterocyclic compounds as FGFR inhibitors
US8895745B2 · kind B2 · utility
24Cited by
18References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 21, 2007 |
| Grant date | Nov 25, 2014 |
| Priority date | — |
| Expiry date | Nov 13, 2029 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to new bicyclic heterocyclic derivative compounds, to pharmaceutical compositions comprising said compounds and to the use of said compounds in the treatment of diseases, e.g. cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.